Skip to Main Content
Table 1

Patients, indications, and protocol

Patient no.SexBody weight (Kg)IndicationaInjected doseb MBqDelay antibody/111 In-tracer (days)Delay111 In-tracer/RIGS (days)
78 133 
76 215 
68 178 
70 148 
53 326 
66 303 
65 263 NDc 
62 118 
64 155 
10 50 303 
11 40 157 
12 83 173 
13 55 178 
Patient no.SexBody weight (Kg)IndicationaInjected doseb MBqDelay antibody/111 In-tracer (days)Delay111 In-tracer/RIGS (days)
78 133 
76 215 
68 178 
70 148 
53 326 
66 303 
65 263 NDc 
62 118 
64 155 
10 50 303 
11 40 157 
12 83 173 
13 55 178 
a

For each patient, the presence of unknown metastases was suspected: A, patients submitted to first surgery for thyroidectomy and bilateral lymph node dissection; B,second surgery in the absence of previous bilateral lymph node dissection; and C, surgery when bilateral lymph node dissection was performed during the first surgery.

b

The bispecific antibody dose was 0.1 mg/kg body weight.

c

ND, not done.

Close Modal

or Create an Account

Close Modal
Close Modal